Orforglipron is the second daily weight-loss pill to hit the market. The first was the Wegovy pill, from Novo Nordisk, which was approved in December 2025 and contains the same substance as Ozempic. The two pills lead to comparable amounts of weight loss in people with obesity.

Here’s how retatrutide works and how it differs from existing weight management medications.